Abeprazan (hydrochloride)
Abeprazan hydrochloride (DWP14012 hydrochloride) is a potassium-competitive acid blocker. Abeprazan hydrochloride inhibits H+, K+- ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan hydrochloride is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases[1].
Product Specifications
CAS Number
1902954-87-3
Product Name Alternative
DWP14012 (hydrochloride) ; Fexuprazan (hydrochloride)
UNSPSC
12352005
Target
Proton Pump
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/abeprazan-hydrochloride.html
Purity
99.87
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
CNCC1=CN(S(=O)(C2=CC=CC(F)=C2)=O)C(C3=CC=C(F)C=C3F)=C1OC.[H]Cl
Molecular Formula
C19H18ClF3N2O3S
Molecular Weight
446.87
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 4
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin, Basic (Type II or HMW) (KRTH/2147R), CF568 conjugate, 0.1mg/mL
